Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 6;25(7):4069.
doi: 10.3390/ijms25074069.

A Novel Fibrin Matrix Derived from Platelet-Rich Plasma: Protocol and Characterization

Affiliations

A Novel Fibrin Matrix Derived from Platelet-Rich Plasma: Protocol and Characterization

Diego Delgado et al. Int J Mol Sci. .

Abstract

Although fibrin matrices derived from Platelet-Rich Plasma (PRP) are widely used in regenerative medicine, they have some limitations that can hinder their application. Modifying the composition of the PRP-derived fibrin matrix may improve its properties, making it suitable for certain medical uses. Three types of fibrin matrices were obtained: a PRP-derived fibrin matrix (FM), a PRP-derived fibrin matrix with a high fibrinogen content and platelets (FM-HFP) and a PRP-derived fibrin matrix with a high fibrinogen content (FM-HF). The fibrinogen levels, biomechanical properties and cell behavior were analyzed. The presence of platelets in the FM-HFP generated an inconsistent fibrin matrix that was discarded for the rest of the analysis. The fibrinogen levels in the FM-FH were higher than those in the FM (p < 0.0001), with a concentration factor of 6.86 ± 1.81. The values of clotting and swelling achieved using the FM-HF were higher (p < 0.0001), with less clot shrinkage (p < 0.0001). The FM had a significantly higher stiffness and turned out to be the most adherent composition (p = 0.027). In terms of cell viability, the FM-HF showed less cell proliferation but higher live/dead ratio values (p < 0.01). The increased fibrinogen and platelet removal in the FM-HF improved its adhesion and other biomechanical properties without affecting cell viability.

Keywords: fibrin; fibrinogen; growth factors; matrix; platelet-rich plasma; platelets; scaffold.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of the data; in the writing of the manuscript or in the decision to publish the results.

Figures

Figure 1
Figure 1
Fibrinogen concentration for matrix preparation. The graph represents the concentration of fibrinogen in blood (basal levels), in the PRP used to prepare the FM and in the fibrinogen concentrate (FC) used to create FM-HF. Error bars = standard deviation (n = 8). Statistically significant differences were calculated using one-way ANOVA (**** p < 0.0001).
Figure 2
Figure 2
Retraction of the matrices. Macroscopic images show the initial volume of FM (A) and FM-HF (B) and the volume after 24 h, showing retraction in FM (C) and not in FM-HF (D).
Figure 3
Figure 3
Surface of the matrices. SEM images show that the FM surface is rougher (A), with more contracted fibrin fibers (B). In contrast, the FM-HF surface is smoother (C), with more evenly arranged fibers (D).
Figure 4
Figure 4
Mechanical properties of the matrices. The graphs represent Young’s modulus (stiffness) (A), the dissipation energy (cushioning) (B) and the adhesion capacity (C) of the FM and the FM-HF. Error bars = standard deviation (n = 8). Statistically significant differences were calculated using Student’s t-test (* p < 0.05; **** p < 0.0001).
Figure 5
Figure 5
Images of live/dead assay. Fluorescence microscope images show live (green) and dead (red) cells at 24 h in the FM (A) and the FM-HF (C) and their evolution after 120 h of culture, with a greater increase in the number of live and dead cells in the FM (B) than in the FM-HF (D). Scale bar = 500 µm (5× objective).
Figure 6
Figure 6
Cell viability. Data show a greater increase in both live and dead cells in the FM (A) than in the FM-HF (B). In both matrices, there is proliferation over time; however, the live/dead ratio is higher in the FM-HF (C). Error bars = standard deviation (n = 4). Statistically significant differences were calculated using Student’s t-test (* p < 0.05; ** p < 0.01).

Similar articles

Cited by

References

    1. Everts P., Onishi K., Jayaram P., Lana J.F., Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int. J. Mol. Sci. 2020;21:7794. doi: 10.3390/ijms21207794. - DOI - PMC - PubMed
    1. Coulange Zavarro A., De Girolamo L., Laver L., Sánchez M., Tischer T., Filardo G., Sabatier F., Magalon J. The Top 100 Most Cited Articles on Platelet-Rich Plasma Use in Regenerative Medicine-A Bibliometric Analysis-From the ESSKA Orthobiologic Initiative. Bioengineering. 2022;9:580. doi: 10.3390/bioengineering9100580. - DOI - PMC - PubMed
    1. Everts P.A.M., Knape J.T.A., Weibrich G., Schönberger J.P.A.M., Hoffmann J., Overdevest E.P., Box H.A.M., van Zundert A. Platelet-Rich Plasma and Platelet Gel: A Review. J. Extra. Corpor. Technol. 2006;38:174–187. doi: 10.1051/ject/200638174. - DOI - PMC - PubMed
    1. Weisel J.W. Advances in Protein Chemistry. Volume 70. Elsevier; Amsterdam, The Netherlands: 2005. Fibrinogen and Fibrin; pp. 247–299. - PubMed
    1. Sánchez-González D.J., Méndez-Bolaina E., Trejo-Bahena N.I. Platelet-Rich Plasma Peptides: Key for Regeneration. Int. J. Pept. 2012;2012:532519. doi: 10.1155/2012/532519. - DOI - PMC - PubMed